Deadly Medicines and Organised Crime

How Big Pharma Has Corrupted Healthcare

Peter Gotzsche, Richard Smith, ummond Rennie

$315

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press
11 July 2017

Medical study & revision guides & reference material; Biology, life sciences; Pharmaceutical technology

This book is devoted to building up the case that the drug industry has systematically corrupted science to play up the benefits and play down the harms of their drugs. It describes the activities of the drug industry to organised crime.

By: Peter Gotzsche
Edited by: Richard Smith, ummond Rennie
Imprint: CRC Press
Country of Publication: United Kingdom
Dimensions: Height: 234mm, Width: 156mm,
Weight: 760g
ISBN: 9781138443471
ISBN 10: 1138443476
Pages: 324
Publication Date: 11 July 2017
Audience: General/trade , Professional and scholarly , ELT Advanced , Undergraduate
Format: Hardback
Publisher's Status: Active

1. Introduction 2. Confessions from an insider 3. Organised crime, the business model of big pharma 4. Very few patients benefit from the drugs they take 5. Clinical trials, a broken social contract with patients 6. Conflicts of interest at medical journals 7. The corruptive influence of easy money 8. What do thousands of doctors on industry payroll do? 9. Hard sell 10. Impotent drug regulation 11. Public access to data at drug agencies 12. Neurontin, an epilepsy drug for everything 13. Merck, where the patients die first 14. Fraudulent celecoxib trial and other lies 15. Switching cheap drugs to expensive ones in the same patients 16. Blood glucose was fine but the patients died 17. Psychiatry, the drug industry’s paradise 18. Pushing children into suicide with happy pills 19. Intimidation, threats and violence to protect sales 20. Busting the industry myths 21. General system failure calls for a revolution 22. Having the last laugh at big pharma

Professor Peter C Gøtzsche graduated as a Master of Science in biology and chemistry in 1974 and as a physician in 1984. He is a specialist in internal medicine; he worked with clinical trials and regulatory affairs in the drug industry 1975–83, and at hospitals in Copenhagen 1984–95. He co-founded The Cochrane Collaboration in 1993 and established The Nordic Cochrane Centre the same year. He became professor of Clinical Research Design and Analysis in 2010 at the University of Copenhagen., Peter Gøtzsche has published more than 50 papers in ‘the big five’ (BMJ, Lancet, JAMA, Annals of Internal Medicine and New England Journal of Medicine) and his scientific works have been cited over 10000 times., Peter Gøtzsche has an interest in statistics and research methodology. He is a member of several groups publishing guidelines for good reporting of research and has co-authored CONSORT for randomised trials (www.consort-statement.org), STROBE for observational studies (www.strobe-statement.org), PRISMA for systematic reviews and meta-analyses (www.prisma-statement.org), and SPIRIT for trial protocols (www.spirit-statement.org). Peter Gøtzsche is an editor in the Cochrane Methodology Review Group.